Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 81
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Zuyi Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Viral Load, Papillomavirus Infections, Genotype, Polymorphism, Genetic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Zunyi Science and Big Data Bureau, Natural Science Foundation of Guizhou Province, Affiliated Hospital of Zunyi Medical University.
Abstract (Originalsprache)
Human papillomavirus (HPV) type 81 has recently become one of the most common low‐risk HPV types; however, literature focusing on it is limited. This study aimed to analyze the reasons for the increased detection rate of HPV81 and investigate its evolving pathogenicity. We analyzed the detection rates and trends of HPV81 in 229 061 exfoliated cervical cell samples collected from 2014 to 2023; collected samples of HPV81 single infections from two different time periods; and analyzed the allele frequencies, positive selection, viral load, persistent infection capacity, and pathogenicity of E6 and E7 genotypes. We found that the detection rate of HPV81 ranked first among the low‐risk types in exfoliated cervical cells and exhibited a significantly increasing trend ( p < 0.001). The frequency of the E6 prototype allele of HPV81 ( n = 317) was significantly increased ( p = 0.018) and demonstrated the strongest adaptive capacity. The viral load and persistent infection capacity of the E6 prototype were significantly higher than those of the mutants, thus serving as key drivers for increasing the detection rate of HPV81 and enhancing its pathogenicity. The viral load was positively correlated with persistent infection capacity and pathogenicity. Persistent infection was a crucial factor in the pathogenicity of HPV81. Successful adaptive evolution of HPV81 is accompanied by enhanced pathogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- School of Laboratory Medicine, Zunyi Medical University, Zunyi, China.
- Department of Information, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Department of Laboratory Medicine, Chongqing Tongnan Women and Children Health Care Hospital, Chongqing, China.
- Department of Laboratory Medicine, Kweichow Moutai Hospital, Renhuai, Guizhou, China.
ORCID-Profile: Daimin Xiao
Förderung
- Zunyi Science and Big Data Bureau
- Natural Science Foundation of Guizhou Province
- Affiliated Hospital of Zunyi Medical University
- National Natural Science Foundation of China
- Guizhou Province "Thousand Talents" Plan
- Affiliated Hospital of Zunyi Medical University Excellent Talents Plan
- Zunyi Science and Technology Cooperation HZ
Zitieren
APA
Chen, Z., Li, Q., Xu, Y., Tian, D., Zhang, M., Guo, Y., Min, X., & Xiao, D. (2024). Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 81. Journal of Medical Virology. https://doi.org/10.1002/jmv.29753
Vancouver
Chen Z, Li Q, Xu Y, Tian D, Zhang M, Guo Y, et al. Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 81. Journal of Medical Virology. 2024. doi:10.1002/jmv.29753
BibTeX
@article{Chen2024,
author = {Chen, Zuyi and Li, Qiongyao and Xu, Yajing and Tian, Di and Zhang, Mingjing and Guo, Yongmei and Min, Xun and Xiao, Daimin},
title = {Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 81},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29753}
}
EUVIMED